FDA Inspection 1167102 — ImmuCell Corporation
The FDA completed an inspection of ImmuCell Corporation on March 29, 2022 in Portland, ME. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). Product area: Veterinary.
Inspection Details
- Classification
- Official Action Indicated (OAI) (OAI)
- End Date
- March 29, 2022
- Fiscal Year
- 2022
- Product Type
- Veterinary
- Project Area
- Pre-Approval Eval. of Animal Drugs and Food Additives
- Location
- Portland, ME (United States)